Document is current
Any future updates will be listed below
-
Authors
Berger, Karin
Moertl, Bernhard
von Bergwelt-Baildon, Michael
Obermüller, Dominik
Pawlowska-Phelan, Dorota
Dreyling, Martin
-
Funding
Funding for this research was provided by:
Klinikum der Universität München
- License Information
-
More Information
Article History
Received: 30 July 2024
Accepted: 19 August 2025
First Online: 2 September 2025
Declarations
:
: Karin Berger is employed at the LMU-Clinic, Department Haematology/Oncology. D. Obermüller and D. Pawlowska-Phelan are employed by InGef-Institute for Applied Health Research Berlin GmbH, which received funding from LMU. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
: This study was approved by a Scientific Committee, consisting of clinical experts from LMU Klinikum and InGef-Insitute for Applied Health Research Berlin. Due to the non-interventional nature of this research, which used a retrospective anonymized claims dataset, no ethical approval was required for this study. The study followed all the dictates of the Declaration of Helsinki.
